Evidence map›Paper›PMID 34960129›Full record

ArticleVaccines2021

Data-Driven Decision Making and Proactive Citizen-Scientist Communication: A Cross-Sectional Study on COVID-19 Vaccination Adherence.

Emil Syundyukov, Martins Mednis, Linda Zaharenko, Eva Pildegovica, Ieva Danovska, Svjatoslavs Kistkins, Abraham Seidmann, Arriel Benis, Valdis Pirags, Lilian Tzivian

Abstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emil SyundyukovLongenesis Ltd., Zaubes str. 9A-23, LV-1013 Riga, Latvia.
Martins MednisLongenesis Ltd., Zaubes str. 9A-23, LV-1013 Riga, Latvia.
Linda ZaharenkoLongenesis Ltd., Zaubes str. 9A-23, LV-1013 Riga, Latvia.
Eva PildegovicaLongenesis Ltd., Zaubes str. 9A-23, LV-1013 Riga, Latvia.ORCID 0000-0003-3810-5484
Ieva DanovskaLongenesis Ltd., Zaubes str. 9A-23, LV-1013 Riga, Latvia.
Svjatoslavs KistkinsDepartment of Internal Medicine, Paul Stradins Clinical University Hospital, Pilsonu str. 13, LV-1002 Riga, Latvia.
Abraham SeidmannQuestrom Business School, Boston University, Boston, MA 02215, USA.
Arriel BenisFaculty of Industrial Engineering and Technology Management, Holon Institute of Technology, Holon 5810201, Israel.ORCID 0000-0002-9125-8300
Valdis PiragsDepartment of Internal Medicine, Paul Stradins Clinical University Hospital, Pilsonu str. 13, LV-1002 Riga, Latvia.
Lilian TzivianFaculty of Medicine, University of Latvia, Jelgavas str. 3, LV-1004 Riga, Latvia.

Funding

National Research Program of the Republic of Latvia (EU) VPP-COVID-2020/1-0025
6 · The paper itself

Abstract

Due to the severe impact of COVID-19 on public health, rollout of the vaccines must be large-scale. Current solutions are not intended to promote an active collaboration between communities and public health researchers. We aimed to develop a digital platform for communication between scientists and the general population, and to use it for an exploratory study on factors associated with vaccination readiness. The digital platform was developed in Latvia and was equipped with dynamic consent management. During a period of six weeks 467 participants were enrolled in the population-based cross-sectional exploratory study using this platform. We assessed demographics, COVID-19-related behavioral and personal factors, and reasons for vaccination. Logistic regression models adjusted for the level of education, anxiety, factors affecting the motivation to vaccinate, and risk of infection/severe disease were built to investigate their association with vaccination readiness. In the fully adjusted multiple logistic regression model, factors associated with vaccination readiness were anxiety (odds ratio, OR = 3.09 [95% confidence interval 1.88; 5.09]), feelings of social responsibility (OR = 1.61 [1.16; 2.22]), and trust in pharmaceutical companies (OR = 1.53 [1.03; 2.27]). The assessment of a large number of participants in a six-week period show the potential of a digital platform to create a data-driven dialogue on vaccination readiness.

Indexed as

coronavirusCOVID-19 vaccination readinessdata-driven communicationdigital healthhealth communicationimmunization programsSARS-CoV-2vaccination hesitancyvaccination refusalweb-based survey

Identifiers

PMID34960129
PMCPMC8703844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.